Combining his interest in art and medical illustration, and creating pop art versions of molecules, has worked wonders […]
Last week I attended an event celebrating the Oxford Refugee Health Initiative.1 It’s not often that I feel […]
Obesity now constitutes a major challenge for healthcare settings around the world, and aetiologically it sits upstream from […]
MDG1011 is a therapy which aims to improve outcomes for in patients with high-risk blood cancers
Treatment involves the treatment of adults with metastatic castration-resistant prostate cancer
The Consort group includes many initiatives to improve reporting of results from randomised controlled trials (RCTs). The original […]
Randomised controlled trials are the reference standard among study designs to investigate the benefits of interventions. These trials […]
A research team has shown in early tests that a bioengineered drug candidate can counter infection with Staphylococcus […]
Despite the promise of new medications that promote cancer cell death in people with acute myeloid leukemia, leukemic […]